Santiago Vázquez Selected Research

Interleukin-22 (IL-22)

10/2022

Glial cell reactivity and oxidative stress prevention in Alzheimer's disease mice model by an optimized NMDA receptor antagonist.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Santiago Vázquez Research Topics

Disease

11	Alzheimer Disease (Alzheimer's Disease) 10/2023 - 01/2018
7	Neuroinflammatory Diseases 10/2023 - 01/2018
6	Cognitive Dysfunction 10/2023 - 10/2017
5	Human Influenza (Influenza) 01/2023 - 01/2012
4	Neurodegenerative Diseases (Neurodegenerative Disease) 12/2023 - 03/2021
3	Pain (Aches) 10/2022 - 01/2021
3	Glucose Intolerance 01/2020 - 10/2016
2	Infections 05/2024 - 01/2020
2	Inflammation (Inflammations) 12/2023 - 03/2021
2	Type 2 Diabetes Mellitus (MODY) 07/2023 - 01/2019
2	Pancreatitis 01/2021 - 10/2020
2	Non-alcoholic Fatty Liver Disease 01/2019 - 01/2018
1	Chronic Pain 12/2023
1	Neuroblastoma 10/2023
1	Obesity 07/2023
1	Cystitis 10/2022
1	Hyperalgesia 10/2022
1	Visceral Pain 10/2022
1	Dementia (Dementias) 07/2022
1	Gliosis 10/2021
1	Type C Niemann-Pick Disease (Niemann Pick Disease, Type C) 03/2021
1	Parkinson Disease (Parkinson's Disease) 01/2020
1	COVID-19 01/2020
1	Body Weight (Weight, Body) 01/2019
1	Neoplasms (Cancer) 01/2018
1	Hemolysis 09/2013
1	Asthenia 04/2004
1	Diarrhea 04/2004
1	Nausea 04/2004
1	Neutropenia 04/2004
1	Breast Neoplasms (Breast Cancer) 04/2004

Drug/Important Bio-Agent (IBA)

11	Epoxide HydrolasesIBA 12/2023 - 01/2020
6	EnzymesIBA 10/2023 - 12/2018
6	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 10/2022 - 01/2018
3	Protons (Proton)IBA 01/2023 - 09/2013
3	Memantine (Namenda)FDA Link 10/2022 - 01/2022
3	Proteins (Proteins, Gene)FDA Link 07/2022 - 01/2012
3	fibroblast growth factor 21IBA 01/2019 - 10/2016
2	Amyloid (Amyloid Fibrils)IBA 10/2023 - 07/2022
2	AminesIBA 01/2023 - 09/2013
2	AcetylcholinesteraseIBA 07/2022 - 01/2022
2	GlucocorticoidsIBA 10/2021 - 12/2018
2	Fatty Acids (Saturated Fatty Acids)IBA 03/2021 - 01/2020
2	LipidsIBA 01/2020 - 10/2016
1	Anti-Bacterial Agents (Antibiotics)IBA 05/2024
1	Growth Differentiation Factor 15IBA 07/2023
1	Amantadine (Aman)FDA LinkGeneric 01/2023
1	Analgesics (Analgesic Drugs)IBA 10/2022
1	Capsaicin (Zostrix)FDA Link 10/2022
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 10/2022
1	Interleukin-22 (IL-22)IBA 10/2022
1	Neuroprotective AgentsIBA 10/2022
1	Neurotransmitter Agents (Neurotransmitter)IBA 07/2022
1	Dizocilpine Maleate (Dizocilpine)IBA 01/2022
1	Ketamine FDA LinkGeneric 01/2022
1	Phencyclidine (Angel Dust)IBA 01/2022
1	6-chlorotacrineIBA 01/2022
1	AcidsIBA 12/2021
1	Reactive Oxygen Species (Oxygen Radicals)IBA 10/2021
1	CholesterolIBA 03/2021
1	GlycosphingolipidsIBA 03/2021
1	CeruletideIBA 01/2021
1	14,15-epoxy-5,8,11-eicosatrienoic acidIBA 01/2020
1	Chloroquine (Aralen)FDA LinkGeneric 01/2020
1	Glucocorticoid Receptors (Glucocorticoid Receptor)IBA 01/2020
1	Hypoglycemic Agents (Hypoglycemics)IBA 01/2019
1	Metformin (Glucophage)FDA LinkGeneric 01/2019
1	CorticosteroneIBA 12/2018
1	Hemagglutinins (Hemagglutinin)IBA 11/2018
1	aniline (aniline hydrobromide)IBA 11/2018
1	LigandsIBA 01/2018
1	Phosphotransferases (Kinase)IBA 01/2018
1	VLDL receptorIBA 01/2018
1	pyrrolidineIBA 10/2017
1	Viral HemagglutininsIBA 09/2013
1	Docetaxel (Taxotere)FDA Link 04/2004
1	Gemcitabine FDA Link 04/2004
1	Transaminases (Aminotransferases)IBA 04/2004

Therapy/Procedure

5	Therapeutics 10/2023 - 04/2004
2	Oral Administration 01/2022 - 01/2019